Literature DB >> 24779035

Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center.

Antoine Gueguen, Matthieu Mahevas, Ruben Nzouakou, Hassan Hosseini, Anoosha Habibi, Dora Bachir, Pierre Brugière, François Lionnet, Jean-Antoine Ribei, Bertrand Godeau, Robert Girot, Vahid Ibrahima, David Calvet, Frédéric Galactéros, Pablo Bartolucci.   

Abstract

Strokes are one of the most severe complications of sickle-cell disease. Most studies have been restricted to children with sickle-cell disease. To better understand the characteristics and follow-up of strokes occurring from childhood to adulthood, we undertook a retrospective cohort study of 69 stroke patients among the 2,875 patients consulting at the French Adult Sickle-Cell Disease Referral Center. Between 1970 and 2008, they had experienced 104 strokes: 80 ischemic, 22 hemorrhagic, and 2 intracranial sinus thromboses. Coma and/or fatal outcomes underscored the severity of strokes in sickle-cell disease patients.Hemorrhagic strokes occurred mostly in adults and carried a higher risk of death than ischemic stroke. The mechanisms underlying sickle-cell disease associated strokes were reevaluated and etiologies were determined for first stroke and recurrences, in childhood and adulthood. Sickle-cell disease vasculopathy concerned only SS patients and remains their most frequent stroke etiology. Cardioembolism, vaso-occlusive crisis and triggering factors were other etiologies identified in adults. Recurrences occurred in 19 SS patients only after a first ischemic stroke. SC patients' strokes occurred in adulthood and were associated with cardiovascular risk factors. Our findings provide novel information about cerebrovascular pathologies throughout the lives of sickle-cell disease patients and suggest the need for different diagnostic and therapeutic management approaches in those different settings.

Entities:  

Mesh:

Year:  2014        PMID: 24779035     DOI: 10.1002/ajh.23625

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Mortal quintet of sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Cumali Gokce; Ramazan Davran; Seckin Akkucuk; Mustafa Ugur; Cem Oruc
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (c-Jun N-Terminal Kinase).

Authors:  Hannah Song; Philip M Keegan; Suhaas Anbazhakan; Christian P Rivera; Yundi Feng; Victor O Omojola; Alexus A Clark; Shuangyi Cai; Jada Selma; Rudolph L Gleason; Edward A Botchwey; Yunlong Huo; Wenchang Tan; Manu O Platt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-12       Impact factor: 8.311

3.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 4.  Clinical biomarkers in sickle cell disease.

Authors:  Ghazi A Damanhouri; Jummanah Jarullah; Samy Marouf; S I Hindawi; Gohar Mushtaq; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-09-18       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.